NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MysmA.01026.a: 4-aminobutyrate transaminase

Target Characteristics

from organism: Mycobacterium smegmatis ATCC 700084 / mc(2)155
most recent status: crystallized
center reference id: MysmA.01026.a
is community request: False
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MysmA.01026.a.A1.GE28859 Full length( MysmA.01026.a ) 1 450 GE28859
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MysmA.01026.a.A1.PW28764 Full length( MysmA.01026.a ) 1 450

External Resources

Resource Reference ID
OrthoMCL: OG5_128761
PATRIC ID: fig|246196.19.peg.6508
RefSeq: YP_890893.1
UniProt: A0R6V5

Enzyme & Pathway Information

Pathway Pathway ID EC Number
superpathway of 4-aminobutanoate degradation 4AMINOBUTMETAB-PWY 2.6.1.19
superpathway of L-arginine, putrescine, and 4-aminobutanoate degradation ARGDEG-PWY 2.6.1.19
beta-alanine degradation I BETA-ALA-DEGRADATION-I-PWY 2.6.1.19
GABA shunt GLUDEG-I-PWY 2.6.1.19
superpathway of L-arginine and L-ornithine degradation ORNARGDEG-PWY 2.6.1.19
nicotine degradation I (pyridine pathway) P181-PWY 2.6.1.19
glutamate degradation IX (via 4-aminobutyrate) PWY3O-210 2.6.1.19
L-glutamate degradation IV PWY-4321 2.6.1.19
4-aminobutanoate degradation V PWY-5022 2.6.1.19
4-aminobutanoate degradation I PWY-6535 2.6.1.19
4-aminobutanoate degradation III PWY-6536 2.6.1.19
4-aminobutanoate degradation II PWY-6537 2.6.1.19

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MTATLTGGPD LQQARRILTE IPGPRSRDLA ERRNAALPAG LASGAGVYIA AAGGGVVVDV DGNSFIDLGS GIAVTTVGNA APAVVSRAGS QLAQYTHTCF LNVPYEPYIE VAERLNALTP GDHQKRTALF STGAEAVENA VKYARAYTGR DAVVVFDHAF HGRSLLTMTM TAKNQPYKHG FGPFAPEVYR APMAYPYRWP SGPENCAAEA FDLFTTLIDA QIGADQVACV VVEPIQGEGG FIVPAEGFLQ KVADFCRERG ILVVADEVQT GIARTGAWFA CEHEDLVPDL ITTAKGLGGG LPLAAVTGRA EIMDAAHAGG IGGTYAGNPV ACAAALGVFD EIEQNGLIER ARAIGEVIVA ELRSIAATTG LIGEIRGRGA MIAVELIKPG TREPNKEAVA ALAKHCHDNG VLTLTAGTFG NVLRFLPPLT ITDELLVDAF GVIRDGFAAL

NT Sequence
ATGACAGCCA CGTTGACGGG CGGACCCGAT CTGCAGCAGG CCCGCCGGAT CCTGACTGAA ATCCCCGGCC CACGGTCCCG TGACCTGGCC GAACGCCGCA ACGCCGCGCT TCCGGCCGGC CTGGCGAGCG GGGCGGGCGT CTACATCGCC GCCGCAGGCG GCGGCGTGGT CGTGGACGTC GACGGCAATT CGTTCATCGA TCTGGGCAGC GGCATCGCGG TCACCACGGT CGGCAACGCC GCACCTGCGG TCGTCTCGCG CGCGGGCAGC CAACTCGCGC AGTACACGCA CACGTGCTTC CTGAACGTGC CCTACGAGCC GTACATCGAG GTCGCCGAGC GTCTCAACGC CCTGACCCCG GGCGATCACC AGAAGCGCAC CGCGCTGTTC AGCACGGGCG CCGAGGCCGT GGAGAACGCC GTCAAGTACG CACGCGCCTA CACCGGTCGC GACGCGGTCG TGGTGTTCGA CCACGCCTTC CACGGCCGGT CGCTGCTCAC CATGACCATG ACGGCCAAGA ACCAGCCCTA CAAGCACGGG TTCGGTCCGT TCGCCCCCGA GGTCTACCGC GCGCCCATGG CCTATCCCTA CCGGTGGCCG TCGGGGCCCG AAAACTGCGC GGCCGAGGCG TTCGACCTGT TCACCACCCT GATCGACGCG CAGATCGGCG CCGATCAGGT GGCCTGCGTC GTGGTCGAAC CCATCCAGGG CGAGGGCGGC TTCATCGTTC CCGCCGAGGG GTTCCTGCAG AAGGTCGCCG ACTTCTGCCG TGAGCGCGGC ATCCTGGTGG TGGCCGACGA GGTGCAGACC GGCATCGCGC GCACCGGCGC GTGGTTCGCG TGCGAGCACG AGGACCTGGT CCCCGACCTC ATCACCACCG CCAAGGGCCT GGGCGGTGGC CTGCCGCTGG CGGCGGTCAC CGGCCGCGCC GAGATCATGG ACGCCGCGCA CGCGGGCGGC ATCGGCGGCA CCTACGCGGG CAACCCCGTC GCGTGCGCCG CAGCACTCGG CGTGTTCGAC GAGATCGAGC AGAACGGCCT GATCGAGCGC GCCCGCGCCA TCGGCGAGGT GATCGTGGCA GAACTGCGCA GCATCGCCGC CACCACCGGC CTCATCGGCG AGATCCGCGG CCGCGGCGCC ATGATCGCCG TCGAGCTGAT CAAGCCCGGC ACGCGCGAAC CCAACAAGGA AGCCGTCGCC GCGCTGGCCA AGCACTGCCA CGACAACGGT GTACTGACCT TGACGGCAGG CACTTTCGGC AATGTCCTGC GTTTCCTGCC GCCGCTGACC ATCACCGACG AACTGCTCGT CGACGCCTTC GGCGTCATCC GCGACGGCTT CGCCGCCCTC

© 2022 Seattle Children's Research Institute. All rights reserved.